Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients
- PMID: 11117546
Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients
Abstract
Axonal degeneration has been proposed as a cause of irreversible neurological disability in multiple sclerosis (MS) patients. The purpose of this study was to quantify axonal loss in spinal cord lesions from 5 paralyzed (Expanded Disability Status Scale score > or =7.5) MS patients and to determine if axonal number or volume correlated with levels of the neuronal marker N-acetyl aspartate (NAA). Axonal loss in MS lesions ranged from 45 to 84% and averaged 68%. NAA levels were significantly reduced (>50%) in cross sections of spinal cords containing MS lesions. Reduced NAA correlated with reduced axonal numbers within lesion areas. In addition, NAA levels per axonal volume were significantly reduced in demyelinated axons (42%) and in myelinated axons in normal-appearing white matter (30%). The data support axonal loss as a major cause of irreversible neurological disability in paralyzed MS patients and indicate that reduced NAA as measured by magnetic resonance spectroscopy can reflect axonal loss and reduced NAA levels in demyelinated and myelinated axons.
Similar articles
-
Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.Neurology. 2007 Jul 3;69(1):63-7. doi: 10.1212/01.wnl.0000265054.08610.12. Neurology. 2007. PMID: 17606882
-
Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.J Neurol. 2003 Feb;250(2):171-8. doi: 10.1007/s00415-003-0965-8. J Neurol. 2003. PMID: 12574947 Clinical Trial.
-
Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.Brain. 2004 Jan;127(Pt 1):89-98. doi: 10.1093/brain/awh002. Epub 2003 Sep 23. Brain. 2004. PMID: 14506072
-
Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.J Neuroimaging. 2004 Jul;14(3 Suppl):5S-10S. doi: 10.1177/1051228404266263. J Neuroimaging. 2004. PMID: 15228754 Review.
-
Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.Exp Neurol. 2010 Sep;225(1):2-8. doi: 10.1016/j.expneurol.2009.10.009. Epub 2009 Oct 17. Exp Neurol. 2010. PMID: 19840788 Review.
Cited by
-
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.Mult Scler. 2013 Apr;19(4):436-42. doi: 10.1177/1352458512458010. Epub 2012 Aug 23. Mult Scler. 2013. PMID: 22917689 Free PMC article.
-
The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.Exp Brain Res. 2017 Jan;235(1):279-292. doi: 10.1007/s00221-016-4789-z. Epub 2016 Oct 5. Exp Brain Res. 2017. PMID: 27709268 Free PMC article.
-
MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosis.Neural Regen Res. 2020 Oct;15(10):1831-1837. doi: 10.4103/1673-5374.280307. Neural Regen Res. 2020. PMID: 32246624 Free PMC article. Review.
-
Bringing CLARITY to gray matter atrophy.Neuroimage. 2014 Nov 1;101:625-32. doi: 10.1016/j.neuroimage.2014.07.017. Epub 2014 Jul 16. Neuroimage. 2014. PMID: 25038439 Free PMC article.
-
The shoulders we keep standing on: remembering Otto Marburg, a big brain in neurology and multiple sclerosis, at 150.Acta Neuropathol. 2024 May 8;147(1):81. doi: 10.1007/s00401-024-02717-x. Acta Neuropathol. 2024. PMID: 38717709 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical